Patients undergoing maintenance hemodialysis develop both structural and functional
cardiovascular abnormalities. Despite improvement of dialysis technology, cardiovascular …

Results During a mean duration of 1.8±1.3 years (maximum of 5 years), the Korean PD
group had a higher mortality rate than the Korean HD group (hazard ratio [HR], 1.20 [95 …

Patients with severely decreased glomerular filtration rate (GFR)(ie, chronic kidney disease
[CKD] G4+) are at increased risk for kidney failure, cardiovascular disease (CVD) events …

Introduction Epidemiological studies consistently show an initial survival advantage for PD
patients compared to HD. It has recently been suggested that this is due to the fact that many …

Background Previous small studies have reported favorable results of peritoneal dialysis
(PD) in the setting of chronic refractory heart failure (CRHF). We evaluated the impact of PD …

Peritoneal dialysis (PD) is an effective renal replacement strategy for patients suffering from
end-stage renal disease. PD offers patient survival comparable to or better than in-center …

Heart failure (HF) is a major comorbidity in patients with end-stage kidney disease (ESKD).
The pathogenesis of HF in patients on renal replacement therapy represents the confluence …

Aims Each episode of acute decompensated heart failure (HF) incrementally adds to
mortality. Peritoneal dialysis (PD) offers an alternative therapeutic option in refractory HF …

Cardiorenal syndrome (CRS) is an increasingly recognized diagnostic entity associated with
high morbidity and mortality among acutely ill heart failure (HF) patients with acute and/or …

Heart failure (HF) and end-stage kidney disease (ESKD) frequently coexist; 1 comorbidity
worsens the prognosis of the other. HF is responsible for almost half the deaths of patients …